Table 5.
Incidence of adverse events following treatment with sildenafil or placebo.
Sildenafil | Placebo | |
---|---|---|
All cause treatment-emergent adverse events (withdrawals) | 14/16 (0) | 7/17 (1)* |
Treatment-related adverse events | 11/16 | 3/17 |
Flushing | 6 | 1 |
Headache | 5 | 1 |
Dizziness | 3 | 1 |
Abnormal vision† | 3 | 0 |
This subject discontinued because of severe back pain related to a slipped disc
each case was a mild and transient disturbance in colour discrimination.